PL394821A1 - Sposób wytwarzania kombrestatyn - Google Patents

Sposób wytwarzania kombrestatyn

Info

Publication number
PL394821A1
PL394821A1 PL394821A PL39482103A PL394821A1 PL 394821 A1 PL394821 A1 PL 394821A1 PL 394821 A PL394821 A PL 394821A PL 39482103 A PL39482103 A PL 39482103A PL 394821 A1 PL394821 A1 PL 394821A1
Authority
PL
Poland
Prior art keywords
combrestinates
production method
production
Prior art date
Application number
PL394821A
Other languages
English (en)
Other versions
PL214129B1 (pl
Inventor
Stéphane Mutti
Michel Lavigne
Irina Malejonock
Jean-Paul Casimir
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of PL394821A1 publication Critical patent/PL394821A1/pl
Publication of PL214129B1 publication Critical patent/PL214129B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/02Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions involving the formation of amino groups from compounds containing hydroxy groups or etherified or esterified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/78Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C217/80Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings
    • C07C217/82Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring
    • C07C217/84Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring the oxygen atom of at least one of the etherified hydroxy groups being further bound to an acyclic carbon atom
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Catalysts (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Magnetic Ceramics (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Detergent Compositions (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
PL394821A 2002-04-11 2003-04-09 Sposób wytwarzania kombrestatyn PL214129B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0204499A FR2838437B1 (fr) 2002-04-11 2002-04-11 Procedes de preparation de combretastatines

Publications (2)

Publication Number Publication Date
PL394821A1 true PL394821A1 (pl) 2011-09-12
PL214129B1 PL214129B1 (pl) 2013-06-28

Family

ID=28459732

Family Applications (3)

Application Number Title Priority Date Filing Date
PL394821A PL214129B1 (pl) 2002-04-11 2003-04-09 Sposób wytwarzania kombrestatyn
PL394820A PL213967B1 (pl) 2002-04-11 2003-04-09 Sposób wytwarzania kombrestatyn oraz zwiazek posredni
PL371629A PL213708B1 (pl) 2002-04-11 2003-04-09 Sposób wytwarzania kombrestatyn

Family Applications After (2)

Application Number Title Priority Date Filing Date
PL394820A PL213967B1 (pl) 2002-04-11 2003-04-09 Sposób wytwarzania kombrestatyn oraz zwiazek posredni
PL371629A PL213708B1 (pl) 2002-04-11 2003-04-09 Sposób wytwarzania kombrestatyn

Country Status (27)

Country Link
EP (3) EP2354118A1 (pl)
JP (1) JP4299677B2 (pl)
KR (1) KR101018983B1 (pl)
CN (1) CN1291970C (pl)
AR (2) AR039198A1 (pl)
AU (1) AU2003260026B2 (pl)
BR (1) BR0309087A (pl)
CA (1) CA2481742C (pl)
CR (1) CR7481A (pl)
EA (1) EA007965B1 (pl)
EC (1) ECSP045348A (pl)
FR (1) FR2838437B1 (pl)
HR (1) HRP20040935A2 (pl)
IL (1) IL164247A0 (pl)
MA (1) MA26407A1 (pl)
ME (1) MEP91508A (pl)
MX (1) MXPA04009112A (pl)
NO (2) NO329701B1 (pl)
NZ (1) NZ535318A (pl)
OA (1) OA12804A (pl)
PL (3) PL214129B1 (pl)
RS (3) RS20110561A3 (pl)
TN (1) TNSN04201A1 (pl)
TW (1) TWI262179B (pl)
UA (1) UA76079C2 (pl)
WO (1) WO2003084919A2 (pl)
ZA (1) ZA200407417B (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7235688B1 (en) 2004-11-04 2007-06-26 University Of Notre Dame Du Lac Process for preparing histone deacetylase inhibitors and intermediates thereof
FR2928148B1 (fr) * 2008-02-28 2013-01-18 Sanofi Aventis Procede de preparation de combretastatine
FR2939665B1 (fr) 2008-12-12 2011-10-07 Sanofi Aventis Combinaison antitumorale associant l'ave8062a et le docetaxel
FR2945210B1 (fr) 2009-05-07 2011-07-01 Sanofi Aventis Combinaison antitumorale comprenant l'ave8062 et le sorafenib
FR2953518B1 (fr) 2009-12-03 2012-01-20 Sanofi Aventis Procede de preparation d'un derive de combretastatine
CA2802974A1 (en) 2010-06-18 2011-12-22 Sanofi An antitumoral combination comprising ombrabulin, a taxane derivative and a platinum derivative
EP2481404A1 (en) 2010-11-15 2012-08-01 Sanofi An antitumoral combination comprising ombrabulin, a taxane derivative and a platinum derivative
EP2397135A1 (en) 2010-06-18 2011-12-21 Sanofi An antitumoral combination comprising ombrabulin, a taxane derivative and a platinum derivative
EP2407161A1 (en) 2010-07-13 2012-01-18 Sanofi An antitumoral combination comprising ombrabulin and bevacizumab
FR2968557A1 (fr) 2010-12-09 2012-06-15 Sanofi Aventis Combinaison antitumorale comprenant un derive de la famille des combretastatines et le cetuximab
FR2978662A1 (fr) 2011-08-01 2013-02-08 Sanofi Sa Combinaison antitumorale comprenant l'ombrabuline et le cisplatine, associee a la radiotherapie
FR2978663A1 (fr) 2011-08-01 2013-02-08 Sanofi Sa Combinaison antitumorale comprenant l'ombrabuline et le cetuximab, associee a la radiotherapie
CN103012248B (zh) * 2013-01-11 2014-11-05 浙江大德药业集团有限公司 氨基康普立停衍生物的合成及其作为口服抗肿瘤药物的应用
EP2805705B1 (en) 2013-05-23 2016-11-09 IP Gesellschaft für Management mbH Packaging with one or more administration units comprising a sodium salt of (R)-3-[6-amino-pyridin-3-yl]-2-(1-cyclohexyl-1 H-imidazol-4-yl)-propionic acid
EP4079327A1 (en) 2021-04-22 2022-10-26 Centaurus Polytherapeutics Payloads for drug-conjugates and their use for treating cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4996237A (en) 1987-01-06 1991-02-26 Arizona Board Of Regents Combretastatin A-4
SU1766257A3 (ru) * 1988-02-24 1992-09-30 Ф.Хоффманн-Ля Рош Аг (Фирма) Способ получени производных стильбена
NZ232897A (en) * 1989-04-03 1992-12-23 Squibb & Sons Inc Interphenylene 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogues, preparation and pharmaceutical compositions thereof
US5731353A (en) * 1993-09-08 1998-03-24 Ajinomoto Co., Inc. Stilbene derivatives and pharmaceutical compositions containing them
TW325458B (en) 1993-09-08 1998-01-21 Ajinomoto Kk Stilbene derivatives and pharmaceutical compositions comprising the same for anti-cancer
WO1995027699A1 (en) * 1994-04-06 1995-10-19 Nippon Shinyaku Co., Ltd. Aminostilbazole derivative and medicine
TW334418B (en) * 1995-03-07 1998-06-21 Ajinomoto Kk Stilbene derivatives and pharmaceutical compositions
JP4551514B2 (ja) * 1999-07-23 2010-09-29 住友化学株式会社 不飽和炭化水素残基置換アニリン類の製造方法
GB9918912D0 (en) 1999-08-12 1999-10-13 Angiogene Pharm Ltd New stilbenes with vascular damaging activity

Also Published As

Publication number Publication date
RS52331B (sr) 2012-12-31
KR101018983B1 (ko) 2011-03-07
IL164247A0 (en) 2005-12-18
JP2005522478A (ja) 2005-07-28
KR20040108717A (ko) 2004-12-24
PL371629A1 (pl) 2005-06-27
EP2354118A1 (fr) 2011-08-10
TWI262179B (en) 2006-09-21
AU2003260026A1 (en) 2003-10-20
AR039198A1 (es) 2005-02-09
EP2348012A1 (fr) 2011-07-27
WO2003084919A2 (fr) 2003-10-16
OA12804A (fr) 2006-07-11
UA76079C2 (en) 2006-06-15
NO20044814L (no) 2004-01-07
EA007965B1 (ru) 2007-02-27
ZA200407417B (en) 2006-04-26
NZ535318A (en) 2007-02-23
HRP20040935A2 (en) 2005-10-31
RS86504A (sr) 2007-02-05
EA200401350A1 (ru) 2005-02-24
PL213708B1 (pl) 2013-04-30
TW200401762A (en) 2004-02-01
TNSN04201A1 (fr) 2007-03-12
BR0309087A (pt) 2005-02-09
NO20101215L (no) 2004-01-07
RS20110561A2 (sr) 2012-10-31
MA26407A1 (fr) 2004-12-01
JP4299677B2 (ja) 2009-07-22
CN1291970C (zh) 2006-12-27
ECSP045348A (es) 2004-11-26
EP1497255A2 (fr) 2005-01-19
CA2481742A1 (fr) 2003-10-16
AU2003260026B2 (en) 2008-01-03
WO2003084919A3 (fr) 2004-04-08
HK1075651A1 (en) 2005-12-23
CA2481742C (fr) 2012-06-19
AR082581A2 (es) 2012-12-19
FR2838437B1 (fr) 2004-06-04
RS20110562A3 (en) 2013-12-31
NO331372B1 (no) 2011-12-12
NO329701B1 (no) 2010-12-06
RS20110561A3 (en) 2013-10-31
PL394820A1 (pl) 2011-09-12
MEP91508A (bs) 2011-12-20
RS20110562A2 (sr) 2012-10-31
PL214129B1 (pl) 2013-06-28
MXPA04009112A (es) 2004-12-07
CN1646476A (zh) 2005-07-27
FR2838437A1 (fr) 2003-10-17
CR7481A (es) 2008-11-25
PL213967B1 (pl) 2013-05-31

Similar Documents

Publication Publication Date Title
CY2015015I1 (el) Παραγωγη τιακουμυκινης
DE60205413D1 (de) Herstellungsverfahren
FI20022084L (fi) Menetelmä valmistaa sanomalehtipaperia
BRPI0313238A2 (pt) método
EE200300420A (et) Vormitiste tootmise meetod
NO20033267L (no) Fremgangsmåter for öket produksjon av av pantothenat
ATA7262002A (de) Fertigungssystem
PL394821A1 (pl) Sposób wytwarzania kombrestatyn
DE602004032525D1 (de) Rstellungsverfahren dafür
IS8447A (is) Aðferð til að framleiða gamma-karboxýleruð prótín
IS8416A (is) Aðferð við framleiðslu á CCR-2 mótlyfi
EP1558772A4 (en) Production of titania
BR0214850B1 (pt) Método de produção de um modelo inconsútil
PL372533A1 (pl) Sposób wytwarzania miedzi konwertorowej
DE602004003115D1 (de) Tonerherstellungsverfahren
FI20021531L (fi) Muurausmenetelmä
NO20023358D0 (no) Metode
IS8333A (is) Aðferð við framleiðslu á THIP
EE200300438A (et) Pantoteenhappe võimendatud produktsiooni meetod
EP1669390A4 (en) POLYAMINOPYRIDINE AND METHOD OF MANUFACTURING THEREOF
FI20021421A0 (fi) Valmistusmenetelmä
ITMI20021432A0 (it) Metodo per produrre cefalosporine
NO20035692D0 (no) Produksjonsmetode
FI20021769A0 (fi) Valmistusmenetelmä
ITFI20030052A1 (it) Metodo per la produzione di argille organofile

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20140409